SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses the potential impact of a failed Alzheimer's drug trial on its stock, despite its dominance in the obesity market with drugs like Wegovy, where community members speculate on the possibility of a price war. Some investors view the dip as a buying opportunity, emphasizing the company's strong fundamentals and long-term potential in the weight loss sector, while others worry about competition from other pharmaceutical companies. There is also discussion around potential acquisitions and partnerships.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending due to reports of a potential extension of Obamacare subsidies, sparking both bullish and bearish sentiments within the community. Bulls anticipate significant gains if the subsidies are extended, while bears express concerns about the company's long-term viability and potential challenges in improving medical loss ratios. Community members are actively discussing potential price targets, entry points, and the overall impact of policy changes on the healthcare sector.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending amid discussions around its potential involvement in the Jeffrey Epstein case and differing opinions on Jamie Dimon's stance on crypto. The community is divided, with some calling for boycotts and others defending the bank's position; also, there is discussion surrounding JPM's recent moves in the crypto space, with some interpreting these moves as hypocritical.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as community members discuss the potential impact of its new Gemini 3 model, with some suggesting it could be a game-changer in the AI race and drive further gains. Bullish sentiment is fueled by positive analyst ratings and Waymo's expansion, while some traders are closely watching for a potential pullback after the recent surge.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide ($WRD) is trending due to robotaxi revenue growth and global expansion milestones, including approvals for driverless operations in Abu Dhabi and partnerships with Uber and Grab. The community is buzzing about the company's potential to monetize AI and compete with Tesla in the robotaxi market. Discussions also highlight WeRide's strategic partnerships and the rapid development of China's autonomous driving technology.

Monad

Monad is trending as its public mainnet launch and token listing approaches, sparking excitement and debate within the crypto community. Discussions revolve around the token distribution process, potential for profit, and where to purchase, alongside speculation about a possible initial price surge and subsequent dip. Some users express concerns about it being a potential scam, while others highlight its listing on Coinbase as a positive sign.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as its Qwen AI app reached 10 million downloads, driving optimism despite broader market AI skepticism. Community members are actively discussing the app's potential to rival ChatGPT and the implications for Alibaba's AI strategy. The news has sparked debate about the stock's valuation and future prospects within the competitive tech landscape.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

MOH is trending as the community discusses its recent rating adjustments from various firms and a significant price drop following disappointing earnings, which missed estimates due to rising medical costs. Community members are weighing the potential for a rebound, citing the company's balance sheet, while others express concerns about sector-wide challenges and potential downgrades. Discussions also revolve around the impact of Medicaid and Medicare policies on the company's revenue streams.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc

Biogen ($BIIB) is trending due to Novo Nordisk's Alzheimer's drug trial failure, boosting interest in BIIB's CNS pipeline. The community is discussing Biogen's potential upside in the Alzheimer's space and recent analyst upgrades. Biogen's strategic focus on CNS and Alzheimer's treatments is being highlighted amid renewed interest in the sector.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

MSI is trending due to community focus on technical analysis, particularly positive divergence and significant dark pool activity suggesting a potential oversold bounce. Traders are pointing to a large dark pool print as a sign of a bottom and reversal. The stock's oversold condition and potential for a bounce are key talking points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Atossa Highlights Emerging Opportunity for (Z)-Endoxifen in Duchenne Muscular Dystrophy, Including Symptomatic Female Carriers, Following Peer-Reviewed Publication and Scientific Presentation

Atossa Highlights Emerging Opportunity for (Z)-Endoxifen in Duchenne Muscular Dystrophy, Including Symptomatic Female Carriers, Following Peer-Reviewed Publication and Scientific Presentation Atossa...

Atossa Genetics (NASDAQ:ATOS) Posts Quarterly Earnings Results, Meets Estimates

Atossa Genetics (NASDAQ:ATOS - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07...

Atossa Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Atossa Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Atossa Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update PR...

Y Intercept Hong Kong Ltd Buys New Shares in Atossa Genetics Inc. $ATOS

Y Intercept Hong Kong Ltd acquired a new stake in shares of Atossa Genetics Inc. (NASDAQ:ATOS - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...

Atossa Genetics Inc. (NASDAQ:ATOS) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Atossa Genetics Inc. (NASDAQ:ATOS - Get Free Report) have received an average recommendation of "Hold" from the five brokerages that are covering the company, Marketbeat Ratings reports...

Atossa Therapeutics Announces Acceptance of Four Abstracts Highlighting (Z)-Endoxifen Research for Presentation at the 2025 San Antonio Breast Cancer Symposium

Atossa Therapeutics Announces Acceptance of Four Abstracts Highlighting (Z)-Endoxifen Research for Presentation at the 2025 San Antonio Breast Cancer Symposium Atossa Therapeutics Announces...

New Strong Sell Stocks for Oct. 22

ATOS, BLIN and CLTP have been added to the Zacks Rank #5 (Strong Sell) List on Oct. 22, 2025.

Atossa Therapeutics Highlights Progress in RECAST DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine Agents

Atossa Therapeutics Highlights Progress in RECAST DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine...

Atossa Therapeutics to Present at the Maxim Growth Summit 2025

Atossa Therapeutics to Present at the Maxim Growth Summit 2025 Atossa Therapeutics to Present at the Maxim Growth Summit 2025 PR Newswire SEATTLE, Oct. 15, 2025 Invites New Investors to Learn More...

Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness

Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to...

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Current Price	$0.7802
Prev Close	$0.752
Open	$0.7533
Dividend Yield	0.00%
50-Day Moving Average	$0.8971
Beta	1.23
Avg. Volume	1.35M
PE Ratio	-3.33

52-Week High	$1.36
52-Week Low	$0.5526
Market Capitalization	$100.78M
EPS (Annual)	-$0.2026
Price to Book	2.02
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ATOS
Atossa Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ATOS News

ATOSAtossa Therapeutics Inc